A sweeping bill would fund the VA to examine ketamine, magic mushrooms and other hallucinogens for potential medical use for ...
Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base ...
Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and ...
Enrollment of pivotal cohort expected to begin in Q1 2026; ATSN-201 BLA submission on track for early 2028DURHAM, N.C., Jan. 08, 2026 (GLOBE ...
The latest announcement is out from Alkermes ( (ALKS) ).
5h
After the killing of John Axelrod, what do we know about the links between mental health and crime?
Most struggling people aren’t violent. Research suggests that severe mental illness can increase the risk — but also suggests ...
AB 250 opens a window stretching from January 1, 2026, to December 21, 2027, lifting the statute of limitations for adult ...
Franklin County Municipal Court is now offering onsite treatment for monthly medication-assisted treatments for opioid ...
News-Medical.Net on MSN
Study: Extended MOUD treatment significantly increases survival probability
A new study of over 32,000 US Veterans has found that the longer people stay on medications for opioid use disorder ...
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...
The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback